» Articles » PMID: 35406382

Posttranslational Modifications in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, Classification, and Treatment

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Apr 12
PMID 35406382
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence that posttranslational modifications, including phosphorylation, acetylation, methylation, ubiquitination, sumoylation, glycosylation, and succinylation, may be involved in thyroid cancer. We review recent reports supporting a role of posttranslational modifications in the tumorigenesis of thyroid cancer, sensitivity to radioiodine and other types of treatment, the identification of molecular treatment targets, and the development of molecular markers that may become useful as diagnostic tools. An increased understanding of posttranslational modifications may be an important supplement to the determination of alterations in gene expression that has gained increasing prominence in recent years.

Citing Articles

Thyroid Carcinoma Glycoproteins Express Altered -Glycans with 3-O-Sulfated Galactose Residues.

Broekhuis J, Lu D, Aryal R, Matsumoto Y, Pepi L, Chaves N Biomolecules. 2025; 14(12.

PMID: 39766189 PMC: 11727208. DOI: 10.3390/biom14121482.


Sirtuin 5-Mediated Desuccinylation of ALDH2 Alleviates Mitochondrial Oxidative Stress Following Acetaminophen-Induced Acute Liver Injury.

Yu Q, Zhang J, Li J, Song Y, Pan J, Mei C Adv Sci (Weinh). 2024; 11(39):e2402710.

PMID: 39159058 PMC: 11497042. DOI: 10.1002/advs.202402710.


Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.

Xiong X, Huang B, Gan Z, Liu W, Xie Y, Zhong J Heliyon. 2024; 10(13):e34032.

PMID: 39091932 PMC: 11292542. DOI: 10.1016/j.heliyon.2024.e34032.


LncRNA ZFAS1 promotes invasion of medullary thyroid carcinoma by enhancing EPAS1 expression via miR-214-3p/UCHL1 axis.

Chen W, Wang S, Wei D, Zhai L, Liu L, Pan C J Cell Commun Signal. 2024; 18(2):e12021.

PMID: 38946718 PMC: 11208124. DOI: 10.1002/ccs3.12021.


SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.

Wu Y, Chen W, Miao H, Xu T BMC Cancer. 2024; 24(1):210.

PMID: 38360598 PMC: 10870498. DOI: 10.1186/s12885-024-11965-9.


References
1.
Miyoshi E, Ito Y, Miyoshi Y . Involvement of aberrant glycosylation in thyroid cancer. J Oncol. 2010; 2010:816595. PMC: 2906155. DOI: 10.1155/2010/816595. View

2.
Mu R, Ma Z, Lu C, Wang H, Cheng X, Tuo B . Role of succinylation modification in thyroid cancer and breast cancer. Am J Cancer Res. 2021; 11(10):4683-4699. PMC: 8569371. View

3.
Liu J, Dong S, Wang H, Li L, Ye Q, Li Y . Two distinct E3 ligases, SCF and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively. FASEB J. 2019; 33(9):10538-10550. PMC: 6704452. DOI: 10.1096/fj.201900415R. View

4.
Taketa K, Endo Y, SEKIYA C, Tanikawa K, Koji T, Taga H . A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993; 53(22):5419-23. View

5.
Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View